Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 11:28 PM
Study NCT ID:
NCT06334393
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-19
First Post:
2024-03-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine Candidate (VLA1601) in Healthy Adults
Sponsor:
Valneva Austria GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-25
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-04-27
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-06
First Submit QC Date:
None
Study First Post Date:
2024-03-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-13
Last Update Post Date:
2025-08-19
Last Update Post Date Type:
ACTUAL